Is this a case of you scratch our back... and we will scratch yours?
Source: GSK Website
Dan Troy has been appointed as Senior Vice President and General Counsel for GlaxoSmithKline (GSK), and will join the company on 2nd September 2008
Dan was formerly Chief Counsel for the US Food and Drug Administration (FDA), where he served as a primary liaison to the White House and the US Department of Health and Human Services (HHS). While leading an office of attorneys who reviewed and approved all major regulations, Dan oversaw the legislative implications of many of the most important issues facing the pharmaceutical industry today, including the reform of the Hatch-Waxman Act and subsequent legislative ratification. His office also approved and managed all agency litigation, and Dan established new procedures for the FDA legal team to follow in preparing and then litigating high-profile cases.
Dan is currently a Partner at the Washington law firm Sidley Austin LLP, where he represents pharmaceutical companies and trade associations on matters related to the FDA and government regulations.
MORE HERE
Hat Tip - Steph Gatchell
Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal
By Bob Fiddaman
ISBN: 978-1-84991-120-7
CHIPMUNKA PUBLISHING
AVAILABLE FOR DOWNLOAD HERE
PAPERBACK COMING SOON
"It's not about what they tell you, it's about what they don't."
~ Bob Fiddaman, Author, Blogger, Researcher, Recipient of two Human Rights awards
Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Subscribe to:
Post Comments (Atom)
Please contact me if you would like a guest post considered for publication on my blog.
2 comments: